1. Pre-Conference Symposium: H eterogeneity in the DSM-5/ DM-ID-2 Autism Spectrum: Linking Biological Traits, Clinical Traits and Treatments Pre-Conference Symposium: H eterogeneity in the DSM-5/ DM-ID-2 Autism Spectrum: Linking Biological Traits, Clinical Traits and Treatments 32 nd ANNUAL National Association for Dual Diagnosis CONFERENCE Nov. 18, 2015 Bryna Siegel, PhD Autism Center of Northern California Dept. of Psychiatry, University of California (Ret.) Elysa Marco, MD Dept. of Neurology, Pediatrics & Psychiatry, University of California Lina Fancy Autism Center of Northern California

2. Three Part Presentation Clinical characterization of ASDs as autism- specific differences in perception, learning& expression (Siegel) Etiologic biological research (neuro-imagining) aimed at illuminating a specific perceptual differences (Marco) Treatment for ASDs around specific differences- integrating behavioral methodology and developmental targets (Fancy)

3. Clinical Characterization Atypical Ontogenetic Processing Primary (e.g., sensory processing) deficits Secondary (accommodations) to deficits Tertiary (failed accommodations) to deficits  Autistic learning disabilities (ALDs) Autistic Learning Styles (ALSs)

4. Etiologic Research Sensory Processing Disorder (SPD) versus Autism Spectrum Disorder (ASD) Examining brain region versus diagnosis

5. Treatment for ASDs Tertiary symptoms=failed accommodations Reducing behavior incompatible with learning Secondary symptoms (ALDs) treated by strategies to overcome: Lack of joint attention (DTT) Lack of affiliative drive (FT/DIR) Auditory processing delays, attn to language (DEV) Development of language through instrumental communication (PRT)